Ostrovnaya I - Search Results

1

Estimating the dose-toxicity curve in completed phase I studies.

Iasonos A, Ostrovnaya I. Iasonos A, et al. Among authors: ostrovnaya i. Stat Med. 2011 Jul 30;30(17):2117-29. doi: 10.1002/sim.4206. Epub 2011 Feb 22. Stat Med. 2011. PMID: 21341302 Free PMC article.

2

A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data.

Ostrovnaya I, Olshen AB, Seshan VE, Orlow I, Albertson DG, Begg CB. Ostrovnaya I, et al. Stat Med. 2010 Jul 10;29(15):1608-21. doi: 10.1002/sim.3866. Stat Med. 2010. PMID: 20205270 Free PMC article.

3

Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.

Balar AV, Apolo AB, Ostrovnaya I, Mironov S, Iasonos A, Trout A, Regazzi AM, Garcia-Grossman IR, Gallagher DJ, Milowsky MI, Bajorin DF. Balar AV, et al. Among authors: ostrovnaya i. J Clin Oncol. 2013 Feb 20;31(6):724-30. doi: 10.1200/JCO.2012.42.5215. Epub 2013 Jan 22. J Clin Oncol. 2013. PMID: 23341513 Free PMC article. Clinical Trial.

4

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.

Apolo AB, Ostrovnaya I, Halabi S, Iasonos A, Philips GK, Rosenberg JE, Riches J, Small EJ, Milowsky MI, Bajorin DF. Apolo AB, et al. Among authors: ostrovnaya i. J Natl Cancer Inst. 2013 Apr 3;105(7):499-503. doi: 10.1093/jnci/djt015. Epub 2013 Feb 14. J Natl Cancer Inst. 2013. PMID: 23411591 Free PMC article.

5

Comparison of properties of tests for assessing tumor clonality.

Ostrovnaya I, Seshan VE, Begg CB. Ostrovnaya I, et al. Biometrics. 2008 Dec;64(4):1018-22. doi: 10.1111/j.1541-0420.2008.00988.x. Epub 2008 Feb 11. Biometrics. 2008. PMID: 18266893 Free PMC article.

6

Phase II study of everolimus in metastatic urothelial cancer.

Milowsky MI, Iyer G, Regazzi AM, Al-Ahmadie H, Gerst SR, Ostrovnaya I, Gellert LL, Kaplan R, Garcia-Grossman IR, Pendse D, Balar AV, Flaherty AM, Trout A, Solit DB, Bajorin DF. Milowsky MI, et al. Among authors: ostrovnaya i. BJU Int. 2013 Aug;112(4):462-70. doi: 10.1111/j.1464-410X.2012.11720.x. Epub 2013 Apr 3. BJU Int. 2013. PMID: 23551593 Free PMC article. Clinical Trial.

7

USING SOMATIC MUTATION DATA TO TEST TUMORS FOR CLONAL RELATEDNESS.

Ostrovnaya I, Seshan VE, Begg CB. Ostrovnaya I, et al. Ann Appl Stat. 2015 Sep;9(3):1533-1548. doi: 10.1214/15-AOAS836. Epub 2015 Nov 2. Ann Appl Stat. 2015. PMID: 26594266 Free PMC article.

8

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma.

Abida W, Milowsky MI, Ostrovnaya I, Gerst SR, Rosenberg JE, Voss MH, Apolo AB, Regazzi AM, McCoy AS, Boyd ME, Bajorin DF. Abida W, et al. Among authors: ostrovnaya i. Bladder Cancer. 2016 Jan 7;2(1):111-117. doi: 10.3233/BLC-150038. Bladder Cancer. 2016. PMID: 27376132 Free PMC article.

9

Estimating the probability of clonal relatedness of pairs of tumors in cancer patients.

Mauguen A, Seshan VE, Ostrovnaya I, Begg CB. Mauguen A, et al. Among authors: ostrovnaya i. Biometrics. 2018 Mar;74(1):321-330. doi: 10.1111/biom.12710. Epub 2017 May 8. Biometrics. 2018. PMID: 28482133 Free PMC article.

10

Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging.

Pandit-Taskar N, Zanzonico P, Hilden P, Ostrovnaya I, Carrasquillo JA, Modak S. Pandit-Taskar N, et al. Among authors: ostrovnaya i. Clin Nucl Med. 2017 Oct;42(10):741-748. doi: 10.1097/RLU.0000000000001752. Clin Nucl Med. 2017. PMID: 28759518 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page